Assessment of the structured clinical interview (SCID) for DSM-5 for somatic symptom disorder in general hospital outpatient clinics in China

Jiang, Yinan; Wei, Jing; Fritzsche, Kurt; Toussaint, Anne; Li, Tao; Cao, Jinya; Zhang, Lan; Zhang, Yaoyin; Chen, Hua; Wu, Haitao; Ma, Xiaoyan; Li, Wentian; Ren, Jie; Lü, Wei; Leonhart, Rainer

doi:10.1186/s12888-021-03126-0

Cited by 10 publications

(7 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Structured clinical interview for DSM-5 disorders-research version (SCID-5-RV) is a semi-structured interview tool for DSM-5 diagnosis and optimal gold standard [ 27 ]. We received approval from the American Psychiatric Association to use the English version of the SCID-5-RV and translated the tool based on the diagnostic criteria for SSD in the Korean version of DSM-5.…”

Section: Methodsmentioning

confidence: 99%

Reliability and Validity of the Korean Version of the Somatic Symptom Disorder-B Criteria Scale in a Clinical Population

Jung,

Shin,

Lee

et al. 2024

Psychiatry Investig

View full text Add to dashboard Cite

Objective This study aimed to develop and validate the Korean version of the Somatic Symptom Disorder-B Criteria Scale (SSD-12) in outpatients at a psychiatric clinic and assess its diagnostic accuracy.Methods A total of 207 patients completed SSD-12. For the diagnostic accuracy of SSD-12, the somatic symptom disorder (SSD) section of the structured clinical interview for DSM-5 disorders-research version (SCID-5-RV) was used. The SSD-12 construct and concurrent validity were assessed by examining the correlations with Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-9 (PHQ-9), PHQ-15, 5-level EQ-5D version (EQ-5D-5L), and World Health Organization Quality of Life Brief Version (WHOQOL-BREF).Results The SSD-12 had excellent internal consistency (Cronbach α=0.90). Confirmatory factor analysis revealed good fit indices for a general factor model (comparative fit index [CFI]=0.92, Tucker-Lewis index [TLI]=0.88, root mean square error of approximation [RMSEA]=0.10; 95% confidence interval [CI], 0.08–0.11) and a three-factor model (CFI=0.94, TLI=0.91, RMSEA=0.08; 95% CI, 0.07–0.10). The total SSD-12 score was significantly correlated with anxiety (GAD-7: r=0.53, p<0.001), depression (PHQ-9: r=0.52, p<0.001), physical symptom burden (PHQ-15: r=0.36, p<0.001), and quality of life (EQ-5D-5L: r=-0.40, p<0.001; WHOQOL-BREF: r=-0.51, p<0.001). SSD-12 demonstrated good accuracy (area under the curve=0.75, standard error=0.04; 95% CI, 0.68–0.82) with an optimal cut-off of 29.Conclusion The Korean SSD-12 demonstrates reliability and validity for diagnosing SSD in clinical setting.

show abstract

Section: Methodsmentioning

confidence: 99%

Reliability and Validity of the Korean Version of the Somatic Symptom Disorder-B Criteria Scale in a Clinical Population

Jung,

Shin,

Lee

et al. 2024

Psychiatry Investig

View full text Add to dashboard Cite

show abstract

“…All patients were interviewed by the validated Chinese version of the SCID‐5 RV for DSM‐5 SSD 15 . The Chinese version correlated highly with somatic symptom severity, emotional distress, and quality of life (all p < 0.001), and could distinguish non‐severe forms of SSD from severe ones.…”

Section: Methodsmentioning

confidence: 99%

Prevalence of DSM‐5 somatic symptom disorder in Chinese patients with breast cancer

Fritzsche

Glinka

et al. 2022

Psycho-Oncology

Self Cite

View full text Add to dashboard Cite

Objective The aims of this study were to explore the frequency of somatic symptom disorder (SSD) and the relationship between SSD and somatic, psychological, and social factors in Chinese patients with breast cancer. Methods This multicenter cross‐sectional study enrolled 264 patients with breast cancer from three different departments in Beijing. The structured clinical interview for fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (SCID‐5) for SSD. Standardized questionnaires and clinical data were used to compare patients with and without SSD. Results Somatic symptom disorder was diagnosed in 21.6% (57/264) of all enrolled patients. No differences were found between SSD patients and non‐SSD patients in terms of sociodemographic characteristics and tumor‐specific variables, except radiotherapy. However, patients with SSD reported higher levels of depression, anxiety and cancer‐related worry. They also showed a longer duration of symptoms, greater impairment in daily life, more concern over their physical complaints and more doctor visits. In a stepwise binary logistic regression analysis, among others, higher health anxiety (WI‐8, Exp(B) = 0.107, p = 0.009) and more doctor visits (OR = −1.841, p < 0.001) showed a significant association with SSD; the model explained 53.7% of the variance. Conclusions Similar to other physical diseases, there is a high prevalence of SSD in patients with breast cancer. Somatic symptom disorder patients differ from non‐SSD patients by exhibiting higher cancer‐related emotional distress and dysfunctional illness perception and behavior. There remain substantial challenges in the diagnosis of SSD in patients with cancer and other medical conditions. Clinical Trial Registration: ChiCTR2100051525.

show abstract

“…The SCID-5-RV for SSD has previously been translated according to the procedures described for the translation of the SSS-8. The validity of the Chinese version in assessing for SSD has been demonstrated ( 22 ).…”

Section: Methodsmentioning

confidence: 99%

Validation of the Chinese version of the Somatic Symptom Scale-8 in patients from tertiary hospitals in China

Wei

Fritzsche

et al. 2022

Front. Psychiatry

Self Cite

View full text Add to dashboard Cite

ObjectiveTo validate the Chinese language version of the Somatic Symptom Scale-8 (SSS-8) in a sample of outpatients attending tertiary hospitals in China.Materials and methodsA Chinese language version of the SSS-8 was completed by outpatients (n = 699) from psychosomatic medicine, gastroenterology/neurology, and traditional Chinese medicine clinics of nine tertiary hospitals between September 2016 and January 2018 to test the reliability. The Patient Health Questionnaire-15 (PHQ-15), the Somatic Symptom Disorder–B Criteria Scale (SSD-12), the Patient Health Questionnaire-9 (PHQ-9), the General Anxiety Disorder-7 (GAD-7) scale, the Medical Outcome Study 12-item Short Form Health Survey (SF-12) and the World Health Organization Disability Assessment Schedule (WHO DAS 2.0) were rated to test construct validity. The criterion validity was tested by using the Semi-structured Clinical Interview for DSM-5 (Research Version) (SCID-5-RV) for somatic symptom disorder (SSD) as the diagnostic gold standard to explore the optimal cutoff score of the SSS-8.ResultsThe average age of the recruited participants was 43.08 (±14.47). 61.4% of them were female. The internal consistency derived from the sample was acceptable (Cronbach α = 0.78). Confirmatory factor analyses resulted in the replication of a three-factor model (cardiopulmonary symptoms, pain symptoms, gastrointestinal and fatigue symptoms) (comparative fit index = 0.95, Tucker-Lewis index = 0.92, root mean square error of approximation = 0.10, 90% confidence interval = 0.08–0.12). The SSS-8 sum score was highly associated with PHQ-15 (r = 0.74, p < 0.001), SSD-12 (r = 0.64, p < 0.001), GAD-7 (r = 0.59, p < 0.001), and PHQ-9 (r = 0.69, p < 0.001). The patients with more severe symptoms showed worse quality of life and disability The optimal cutoff score of SSS-8 was 9 (sensitivity = 0.67, specificity = 0.68).ConclusionOur preliminary assessment suggests that the Chinese language version of the SSS-8 has reliability and validity sufficient to warrant testing further in research and clinical settings.

show abstract

Assessment of the structured clinical interview (SCID) for DSM-5 for somatic symptom disorder in general hospital outpatient clinics in China

Cited by 10 publications

References 23 publications

Reliability and Validity of the Korean Version of the Somatic Symptom Disorder-B Criteria Scale in a Clinical Population

Reliability and Validity of the Korean Version of the Somatic Symptom Disorder-B Criteria Scale in a Clinical Population

Prevalence of DSM‐5 somatic symptom disorder in Chinese patients with breast cancer

Validation of the Chinese version of the Somatic Symptom Scale-8 in patients from tertiary hospitals in China

Contact Info

Product

Resources

About